Odee: Gregory Harris
OfbọChị Okike: 10 Onwa Epurel 2021
DatebọChị Mmelite: 4 Novemba 2024
Anonim
L-Триптофан и 5-HTP что это? Как принимать от депрессии, бессонницы и для похудения?
Vidio: L-Триптофан и 5-HTP что это? Как принимать от депрессии, бессонницы и для похудения?

Ndinaya

5-HTP (5-hydroxytryptophan) bụ kemịkal sitere na ngwaahịa nke protin protein L-tryptophan. E mekwara ya n’ahịa site na mkpuru osisi Africa ana-akpọ Griffonia simplicifolia.

A na-eji 5-HTP eme ihe maka nsogbu ihi ụra dị ka ehighị ụra nke ọma, nkụda mmụọ, nchekasị, na ọtụtụ ọnọdụ ndị ọzọ, mana enweghị ezigbo ihe mmụta sayensị iji kwado ọtụtụ n'ime ojiji ndị a.

Natural Medicines Comprehensive database ọnụego na-arụ ọrụ dabere na ihe akaebe sayensị dịka usoro a si dị: Mmetụta, Ikekwe Ọ Ga-arụpụta Ihe, Ikekwe Ọ Ga-arụpụta Ihe, Ikekwe Ọ Dị Irè, Ikekwe Ọ Dị Irè, Adịghị Eme Ihe, na Ego ezughi ezu iji gosi.

Radị irè maka 5-HTP ndị dị ka ndị a:

Ekwe omume irè n'ihi na ...

  • Nsogbu. Inweta 5-HTP site na ọnụ yiri ka ọ na-eme ka mgbaàmà nke ịda mbà n'obi ụfọdụ ndị ka mma. Clinicalfọdụ nnyocha nyocha na-egosi na ị 5ụ 5-HTP site n'ọnụ nwere ike ịba uru dị ka ụfọdụ ọgwụ ọgwụ antidepressant iji meziwanye mgbaàmà ịda mbà n'obi. N'ọtụtụ ọmụmụ, a na-ewere 150-800 mg kwa ụbọchị nke 5-HTP. N'ọnọdụ ụfọdụ, ejirila ọgwụ dị elu.

Ikekwe adighi ike maka ...

  • Ọrịa Down. Researchfọdụ nnyocha na-egosi na ịnye ụmụ ọhụrụ 5-HTP nsogbu Down syndrome nwere ike melite ahụ ike na ọrụ. Nchọpụta ndị ọzọ na-egosi na ọ naghị eme ka ahụ ike ma ọ bụ mmepe mgbe ọ malitere site na nwata ruo afọ 3-4. Nnyocha na-egosikwa na ị na-ewere 5-HTP yana ọgwụ ọgwụ eji eme ihe na-eme ka mmepe, nka mmekọrịta, ma ọ bụ nka asụsụ.

Ezughi oke akaebe iji gosipụta irè maka ...

  • Anxietydị nchekasị nke akara site na echiche ugboro ugboro na omume ugboro ugboro (nsogbu na-agwụ aghara ma ọ bụ OCD). Nnyocha mbụ emere na-egosi na ị takingụ 5-HTP na ọgwụ antidepressant fluoxetine (Prozac) maka izu 12 nwere ike melite ụfọdụ mgbaàmà nke OCD.
  • Mmanya na-a disorderụ mmanya. Nnyocha mbụ mere na-egosi na ị takingụ 5-HTP na D-phenylalanine na L-glutamine maka ụbọchị 40 nwere ike belata mgbaàmà ị alcoholụ mmanya. Otú ọ dị, ị 5ụ 5-HTP na carbidopa kwa ụbọchị maka otu afọ adịghị ka ọ ga - enyere ndị mmadụ aka ịkwụsị ị drinkingụ mmanya. Mmetụta nke 5-HTP naanị maka mmanya na-egbu adịghị edozi.
  • Ọrịa Alzheimer. Nnyocha mbụ na-egosi na ị takingụ 5-HTP site n'ọnụ anaghị enyere mgbaàmà nke ọrịa Alzheimer aka.
  • Nchegbu. Ihe akaebe banyere mmetụta nke 5-HTP maka nchegbu edoghị anya. Nnyocha mbụ mere na-egosi na iji 25-150 mg nke 5-HTP site n'ọnụ kwa ụbọchị yana carbidopa yiri ka ọ ga-ebelata mgbaàmà nchegbu na ndị nwere nsogbu nchegbu. Otú ọ dị, nchọpụta mbụ ndị ọzọ na-egosi na ị showsụ ọgwụ 5-HTP dị elu, 225 mg kwa ụbọchị ma ọ bụ karịa, yiri ka ọ na-eme ka nchekasị ka njọ. Ọzọkwa, ịnara 60 mg nke 5-HTP kwa ụbọchị site na akwara adịghị belata nchekasị na ndị nwere nsogbu ụjọ.
  • Mbibi ụbụrụ nke na-emetụta ahụ ike (cerebellar ataxia). Ihe akaebe banyere ojiji nke 5-HTP maka cerebellar ataxia adịghị edozi. Ihe akaebe mbu na-egosi na ị takingụ 5 mg / kg nke 5-HTP kwa ụbọchị maka ọnwa 4 nwere ike belata nkwụsị ụjọ ụjọ. Otú ọ dị, nchọpụta ndị ọzọ na-egosi na ị 5ụ 5-HTP kwa ụbọchị ruo otu afọ adịghị eme ka mgbaàmà nke ataxia cerebellar dị mma.
  • Fibromyalgia. Nnyocha mbụ na-egosi na ị takingụ 100 mg nke 5-HTP ugboro atọ kwa ụbọchị maka ụbọchị 30-90 nwere ike imeziwanye ihe mgbu, ịdị nro, ụra, nchekasị, ike ọgwụgwụ, na isi ike ụtụtụ na ndị nwere fibromyalgia.
  • Mgbaàmà nke nsọ nwanyị. Nnyocha mbụ emere na-egosi na ị 150ụ 150 mg nke 5-HTP kwa ụbọchị maka izu 4 anaghị belata ọkụ ọkụ na ụmụ nwanyị postmenopausal.
  • Migraine. Ihe akaebe banyere mmetụta nke 5-HTP maka igbochi ma ọ bụ ọgwụgwọ nke mpụga na ndị okenye adịghị edozi. Studiesfọdụ ọmụmụ na-egosi na ị na-ewere 5-HTP kwa ụbọchị anaghị belata mpụga, ebe ọmụmụ ndị ọzọ na-egosi na ọ nwere ike ịba uru dị ka ọgwụ ọgwụ. 5-HTP adịghị ka ọ ga-ebelata oke isi ọwụwa ụmụaka.
  • Ibu. Nnyocha emere na mbụ na-egosi na ị were 5-HTP nwere ike inye aka belata agụụ, kalori oriri, yana ịdị arọ nke ndị buru ibu. Nchọpụta ndị ọzọ na-atụ aro na iji ntanye akọwapụtara nke nwere 5-HTP na mpempe akwụkwọ ndị ọzọ (5-HTP-Nat Exts, Medestea Biotech SpA, Torino, )tali) maka izu 4 na-abawanye ọnwụ dị ihe dịka 41% na ụmụ nwanyị postmenopausal buru oke ibu.
  • Nwepu na heroin, morphine, na ọgwụ ndị ọzọ opioid. Nnyocha mbụ mere na-atụ aro na ị takingụ 200 mg nke 5-HTP kwa ụbọchị maka ụbọchị 6 yana tyrosine, phosphatidylcholine, na L-glutamine, nwere ike belata ụra ehighị ụra na mgbaàmà nke iwepụ na mgbake nke ọgwụ heroin.
  • Ọrịa Parkinson. Nnyocha mbụ mere na-egosi na ị 100ụ 100-150 mg nke 5-HTP kwa ụbọchị na ọgwụ ọgwụ ndị yiri ka ọ ga-ebelata ịma jijiji, mana uru ndị a na-aga n'ihu ruo ọnwa 5. Nnyocha ndị ọzọ emere n'oge na-egosi na ịnara 50 mg nke 5-HTP kwa ụbọchị nwere ike belata mgbaàmà nke mmegharị mmegharị site na ọgwụ levodopa, yana mgbaàmà nke ịda mbà n'obi, na ndị nwere ọrịa Parkinson. Mana iburu 5-HTP buru ibu, 275-1500 mg kwa ụbọchị, yana carbidopa nwere ike njọ ụfọdụ mgbaàmà.
  • Ọrịa mgbu. Nnyocha mbụ na-egosi na ị 100ụ 100 mg nke 5-HTP ugboro atọ kwa ụbọchị maka izu 8 anaghị belata ihe mgbu ma ọ bụ ogologo isi ọwụwa.
  • Ntị mpe-hyperactivity disorder (ADHD).
  • Ehighị ụra nke ọma.
  • Ọrịa dysphoric premenstrual (PMDD).
  • Ọrịa Premenstrual (PMS).
  • Ọrịa Ramsey-Hunt.
  • Ọnọdụ ndị ọzọ.
A na - achọ ihe akaebe iji chọpụta arụmọrụ nke 5-HTP maka ojiji ndị a.

5-HTP na-arụ ọrụ n'ime ụbụrụ na usoro ụjọ nke etiti site na ịba ụba mmepụta nke serotonin kemịkal. Serotonin nwere ike imetụta ụra, agụụ, ọnọdụ okpomọkụ, omume mmekọahụ, na mgbu mgbu. Ebe 5-HTP na-abawanye njikọ nke serotonin, a na-eji ya maka ọtụtụ ọrịa ebe serotonin kwenyere na ọ ga-arụ ọrụ dị mkpa gụnyere ịda mba, ehighị ụra nke ọma, oke ibu, na ọtụtụ ọnọdụ ndị ọzọ.

Mgbe e were ya n'ọnụ: 5-HTP bu Enwere ike nchekwa mgbe ị na-ewere ọnụ n'ụzọ kwesịrị ekwesị. Ejiri ya na nchekwa na 400 mg kwa ụbọchị ruo otu afọ. Mana ụfọdụ ndị mmadụ ewerela 5-HTP mepụtara ọnọdụ akpọrọ eosinophilia-myalgia syndrome (EMS). EMS bụ ọnọdụ dị njọ metụtara oke nro dị nro (myalgia) na ọdịiche ọbara (eosinophilia). Peoplefọdụ ndị na-eche na EMS nwere ike ibute site na ihe ọghọm na ihe ọghọm na ụfọdụ ngwaahịa 5-HTP. Mana enweghi ihe omuma sayensi zuru ezu iji mara ma ọ bụ 5-HTP kpatara EMS, mmetọ, ma ọ bụ ihe ọzọ. Ruo mgbe amara karịa, 5-HTP kwesịrị iji nlezianya mee ihe.

Mmetụta ndị ọzọ nwere ike ịbụ 5-HTP gụnyere obi mgbu, afọ mgbu, ọgbụgbọ, ọgbụgbọ, afọ ọsịsa, ụra, nsogbu mmekọahụ, na nsogbu ahụ ike.

5-HTP bu EBEGH UN UNSAFE mgbe ejiri ọnụ na nnukwu doses. Agbanye site na gram 6-10 kwa ụbọchị ejikọtara yana nsogbu afọ na oke ahụ ike.

Akpachapụ anya na ịdọ aka na ntị:

Ime ime na ara-ara: Enweghi ozi zuru ezu zuru ezu ịmara ma ọ bụrụ na 5-HTP dị mma iji mee ihe mgbe ọ dị ime ma ọ bụ na-enye nwa ara. Nọrọ na mma n'akụkụ ma zere ojiji.

Mụaka: 5-HTP bu Enwere ike nchekwa mgbe ejiri onu were ya. A na-eji usoro ihe ruru 5 mg / kg kwa ụbọchị n'enweghị nsogbu ọ bụla ruo afọ 3 na ụmụ ọhụrụ na ụmụaka ruo 12 afọ. Dị ka ọ dị n'ebe ndị okenye nọ, enwerekwa nchegbu banyere ikike eosinophilia-myalgia syndrome (EMS) nwere n'ebe ụmụaka nọ, ọnọdụ dị njọ nke metụtara ịdị nro dị ukwuu (myalgia) na nsogbu ọbara (eosinophilia).

Gerywa ahụ: 5-HTP nwere ike imetụta ụbụrụ chemical akpọ serotonin. Drugsfọdụ ọgwụ a na-enye n'oge ịwa ahụ nwekwara ike imetụta serotonin. Inweta 5-HTP tupu ịwa ahụ nwere ike ibute serotonin n'ụbụrụ ma nwee ike ibute nsonaazụ dị egwu gụnyere nsogbu obi, ịma jijiji, na nchekasị. Gwa ndị ọrịa ka ha kwụsị ị takingụ 5-HTP opekata mpe izu abụọ tupu ịwa ahụ.

Isi
Ejila nchikota a.
Ọgwụ maka ịda mba (MAOIs)
5-HTP na - eme ka kemikal na ụbụrụ a na - akpọ serotonin. Ọgwụ ụfọdụ ejiri maka ịda mba na-emekwa ka serotonin dịkwuo elu. 5nara 5-HTP na ọgwụ ndị a maka ịda mbà nwere ike ime ka serotonin dị ukwuu. Nke a nwere ike ibute nsonaazụ dị egwu gụnyere oke isi ọwụwa, nsogbu obi, ịma jijiji, mgbagwoju anya, na nchekasị.

Fọdụ n'ime ọgwụ ndị a eji ada mbà n'obi gụnyere phenelzine (Nardil), tranylcypromine (Parnate), na ndị ọzọ.
Agafeghị oke
Kpachara anya na nchikota a.
Carbidopa (Lodosyn)
5-HTP nwere ike imetụta ụbụrụ. Carbidopa (Lodosyn) nwekwara ike imetụta ụbụrụ. Inweta 5-HTP tinyere carbidopa nwere ike ime ka ohere nke nsonaazụ dị egwu gụnyere okwu ngwangwa, nchekasị, ime ihe ike, na ndị ọzọ.
Ọgwụ ịgwọ ọrịa (CNS depressants)
5-HTP nwere ike ibute ụra na iro ụra. A na-akpọ ọgwụ ndị na-akpata ihi ụra ụra. 5nara 5-HTP tinyere ọgwụ ndọtị nwere ike ibute oke ụra.

Somefọdụ ọgwụ na-akụda mmụọ gụnyere clonazepam (Klonopin), lorazepam (Ativan), phenobarbital (Donnatal), zolpidem (Ambien), na ndị ọzọ.
Ọgwụ Serotonergic
5-HTP nwere ike ime ka kemịkal dị na ụbụrụ a na-akpọ serotonin. Medicationsfọdụ ọgwụ na-eme ka serotonin dịkwuo elu. 5nara 5-HTP tinyere ọgwụ ndị a nwere ike ime ka serotonin dị ukwuu. Nke a nwere ike ibute nsonaazụ dị egwu gụnyere oke isi ọwụwa, nsogbu obi, ịma jijiji, mgbagwoju anya, na nchekasị.

Fọdụ n'ime ọgwụ ndị a gụnyere fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft), amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Tofranil), sumatriptan (Imitrex), zolmitriptan (Zomig), rizatriptan (rizatriptan) methadone (Dolophine), tramadol (Ultram), na ọtụtụ ndị ọzọ.
Herbs na Mmeju na ogwuura Njirimara
5-HTP nwere ike ibute ụra ma ọ bụ iro ụra. Iji ya na ahihia ndi ozo na ihe ndi ozo nke nwere otu ihe puru ime ka ura buru oke ura. Fọdụ n'ime mkpá akwụkwọ na ọgwụ ndị a gụnyere calamus, California poppy, catnip, hops, Jamaican dogwood, kava, St. John's wort, skullcap, valerian, yerba mansa, na ndị ọzọ.
Herbs na mgbakwunye na ihe serotonergic
5-HTP na - abawanye ụbụrụ ụbụrụ a na - akpọ serotonin. Iwere 5-HTP tinyere ahịhịa na ọgwụ ndị ọzọ na-eme ka serotonin nwee ike ibute serotonin nke ukwuu ma kpatara nsonaazụ gụnyere nsogbu obi, ịma jijiji na nchekasị. Nkpuru ahihia ndi ozo na ihe ndi na eme ka serotonin di elu bu Hawaiian woodrose, L-tryptophan, S-adenosylmethionine (SAMe), na St. John’s wort.
Enweghi mmekorita ya na ihe oriri.
A na-amụ usoro ndị a na nyocha sayensị: NDUL okenye

Site n'ọnụ:
  • Maka ịda mbà n'obi: Ọtụtụ mgbe, a na-ewere 150-800 mg kwa ụbọchị maka izu 2-6. A na - ekewa usoro a mgbe ụfọdụ ma nye ya dị ka 50 mg na 100 mg ugboro atọ n'ụbọchị. Mgbe ụfọdụ ọgwụ ahụ na-amalite ala ma na-arịwanye elu kwa izu 1-2 ọ bụla ruo mgbe ezubere iche. Obere ihe, a na-eji doses dị elu. N'ime otu ọmụmụ, a na-amụba ọgwụ ahụ ruo gram 3 kwa ụbọchị.
2-Amino-3- (5-Hydroxy-1H-Indol-3-yl) Propanoic Acid, 5 Hydroxy-Tryptophan, 5 Hydroxy-Tryptophane, 5-Hydroxytryptophan, 5-Hydroxytryptophane, 5-Hydroxy L-Tryptophan, 5-Hydroxy L-Tryptophane, 5-Hydroxy Tryptophan, 5-L-Hydroxytryptophan, L-5 HTP, L-5-Hydroxytryptophan, L-5-Hydroxytryptophane, Oxitriptan.

Iji mụtakwuo banyere otú e si dee isiokwu a, biko lee Natural Medicines Comprehensive database usoro.


  1. Meloni M, Puligheddu M, Sanna F, et al. Nrụpụta ọrụ na nchekwa nke 5-Hydroxytryptophan na levodopa na-ebute nsogbu ọgba aghara na ọrịa Parkinson: Nchọpụta mbido. NJ Neurol Sci. 2020; 415: 116869. Lelee anya.
  2. Yousefzadeh F, Sahebolzamani E, Sadri A, et al. 5-Hydroxytryptophan dị ka ọgwụgwọ adjuvant na ọgwụgwọ nke oke nsogbu siri ike na-agwụ ike: ikpe abụọ a na-ahụ anya nke ọma na njikwa placebo. Int Clinic Psychopharmacol. 2020; 35: 254-262. Lelee anya.
  3. Javelle F, Lampit A, Bloch W, Häussermann P, Johnson SL, Zimmer P. Mmetụta nke 5-hydroxytryptophan na ụdị ịda mbà n'obi dị iche iche: nyocha nhazi na meta-analysis. Nutr Rev 2020; 78: 77-88. Lelee anya.
  4. Meloni M, Puligheddu M, Carta M, Cannas A, Figorilli M, Defazio G. fficrụ ọrụ na nchekwa nke 5-hydroxytryptophan na ịda mba na enweghị mmasị na ọrịa Parkinson: nchọpụta mmalite. Eur J Neurol 2020; 27: 779-786. Lelee anya.
  5. Israelyan N, Del Colle A, Li Z, et al. Mmetụta nke Serotonin na Nwepu-Nwepu 5-Hydroxytryptophan na Gastrointestinal Motility in Mouse Model of Depression. Ọrịa. Ọrịa. 2019; 157: 507-521.e4. Lelee anya.
  6. Michelson D, Page SW, Casey R, et al. Nsogbu metụtara eosinophilia-myaligia nke metụtara nsogbu na l-5-hydroxytryptophan. J Rheumatol 1994; 21: 2261-5. Lelee anya.
  7. Lemaire PA, Adosraku RK. Usoro HPLC maka nyocha nke serotonin precursor, 5-hydroxytrophan, na mkpụrụ nke Griffonia simplicifolia. Phytochem Anal 2002; 13: 333-7. Lee anya.
  8. Rondanelli M, Opizzi A, Faliva M, Bucci M, Perna S. Mmekọrịta dị n'etiti nsị nke 5-hydroxytryptophan sitere na nri agbakwunyere, site na nchịkọta Griffonia simplicifolia, yana mmetụta na satiety na ụmụ nwanyị buru oke ibu mgbe ejiri ọgwụ nchịkwa. Rie Nsogbu Ọrịa 2012; 17: e22-8. Lelee anya.
  9. Pardo JV. Mania na-agbakwunye mgbakwunye hydroxytryptophan na monoamine oxidase inhibitor. Ọrịa Ọrịa Gen 2012, 34: 102.e13-4.
  10. Chen D, Liu Y, He W, Wang H, Wang Z. Neurotransmitter-precursor-supplement intervention maka detoxified heroin riri ahụ. J Huazhong Univ Sci Teknụzụ Med Sci 2012; 32: 422-7.
  11. Gendle MH, Nwa agbọghọ EL, Romano AC. Mmetụta nke 5-hydroxytryptophan ọnụ na ọrụ nhazi atụmatụ: nghọta n'ime mmekọrịta mmekọrịta dopamine / serotonin na ụbụrụ dị n'ihu. Hum Psychopharmacol 2013; 28: 270-3.
  12. Nchịkọta Kọmitii Ndụmọdụ Nlekọta Ọgwụ na Ọgwụ nke United States na June 17-18, 2015. A na-enweta ya na: www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/pharmacycompoundingadvisorycommittee/ucm455276.pdf (enweta 8/21/15).
  13. Nchịkwa nri na ọgwụ ọjọọ na U.S. Ntuziaka na nnabata ụmụ mgbei. A na-enweta ya na: www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm (nweta 8/20/2015).
  14. Das YT, Bagchi M, Bagchi D, Preuss HG. Nchedo nke 5-hydroxy-L-tryptophan. Akwụkwọ Toxicol Lett 2004; 150: 111-22. Lelee anya.
  15. Weise P, Koch R, Shaw KN, Rosenfeld MJ. Ojiji nke 5-HTP na ọgwụgwọ nke Down’s syndrome. Ọrịa ụmụaka 1974; 54165-8. Lelee anya.
  16. Bazelon M, Paine RS, Cowie VA, et al. Ngbanwe nke hypotonia na ụmụ ọhụrụ nwere nsogbu Down site na nchịkwa nke 5-hydroxytryptophan. Akwụkwọ Lanyere 1967; 1: 1130-3. Lelee anya.
  17. Sano I. ọgwụgwọ nke ịda mbà n'obi na L-5-hydroxytryptophan (L-5-HTP). Ọrịa na Neurologia Japonicas 1972; 74: 584.
  18. Klein P, Lees A, na Stern G. Ihe na-akpata 5-hydroxytryptophan na-adịghị ala ala na nkwarụ na-arịa ọrịa na-arịa ọrịa na-adịghị mma na nsogbu na nsogbu ndị ọzọ na-adịghị mma. Neuro Neurol 1986; 45: 603-604.
  19. VanPraag, H. M. na Korf, J. 5-Hydroxytryptophan dị ka antidepressant: Uru amụma nke ule probenecid. Psychopharmacol.Bull. Ọrịa. 1972; 8: 34-35.
  20. Sicuteri F. 5-hydroxytryptophan na prophylaxis nke migraine. Nkwukọrịta Nyocha Ọgwụ na 1972; 4: 213-218.
  21. Rosano Burgio, F., Borgatti, R., Scarabello, E., na Lanzi, G. Isi ọwụwa na ụmụaka na ndị nọ n’afọ iri na ụma. Usoro nke International Symposium nke isi ọwụwa na ụmụaka na ndị na-eto eto. 1989; 339-47.
  22. Okechukwu NT. 5-hydroxytryptophan na prophylaxis nke migraine: nyocha ihu abụọ. Isi ọwụwa 1978; 18: 111.
  23. De Benedittis G, Massei R. 5-HT precursors na migraine prophylaxis: nyocha ihu abụọ na-aga n'ihu na L-5-hydroxytryptophan. Ọrịa J Pain 1986; 2: 123-129.
  24. Wyatt, R.J, Vaughan, T., Kaplan, J., Galanter, M., na Green, R. 5-Hydroxytryptophan na-adịghị ala ala schizophrenia. Na: Barchas J na Usdin E. Serotonin na Àgwà. New York: Acedemic Press; 1973.
  25. Brodie HKH, Sack R, na Siever L. Clinical studies of L-5-hydroxytryptophan in depression. Na: Barchas J na Usdin E. Serotonin na omume. New York: Ọmụmụ Press; 1973.
  26. Auffret, M., Comte, H., na Bene, J. Eosinophilia-myalgia syndrome nke L-5 hydroxytryptophane kpatara: ihe dị ka ikpe atọ. Fund Clinic 2013; Suppl 1: akwụkwọ mpịakọta P2-204.
  27. Cangiano C, Laviano A, Del Ben M, et al. Mgbakwunye Mmetụta nke 5-hydroxy-tryptophan ọnụ na oriri ike na nhọrọ macronutrient na ndị na-abụghị ndị na-arịa ọrịa shuga na-abụghị insulin. Int J Obes Relat Metab Nsogbu 1998; 22: 648-54. Lelee anya.
  28. Ju, C. Y. na Tsai, C. T. Serotonergic usoro metụtara iwepu nri site na 5-HTP na oke. Chin J Physiol 1995; 38: 235-240. Lelee anya.
  29. Pranzatelli, M. R., Tate, E., Galvan, I., na Wheeler, A. A na-anwale ikpe nke 5-hydroxy-L-tryptophan maka ataxia na-aga n'ihu na myoclonus epilepsy. Neurolọ Neurol Neurosurg. 1996; 98: 161-164. Lelee anya.
  30. Frith, C. D., Johnston, E. C., Joseph, M. H., Powell, R.J, na Watts, R. W. Nnwale ihu abụọ nke ụlọ ọgwụ nke 5-hydroxytryptophan n'ihe banyere ọrịa Lesch-Nyhan. Ọrịa Neurol Neurosurg. Ọrịa 1976; 39: 656-662. Lelee anya.
  31. Bastard, J., Truelle, J. L., na Emile, J. [Irè nke 5 hydroxy-tryptophan na ọrịa Parkinson]. Nouv Presse Med 9-11-1976; 5: 1836-1837. Lelee anya.
  32. Trouillas P, Serratrice G, Laplane D, et al. Vodị Levorotatory 5-hydroxytryptophan na Friedreich’s ataxia. Nsonaazụ nke ọgwụ abụọ-placebo na-ekwenye ekwenye na ọgwụ abụọ. Arch Neurol 1995; 52: 456-60. Lelee anya.
  33. Wessel K, Hermsdörfer J, Deger K, et al. Ugboro abụọ kpuru ìsì ọmụmụ na levorotatory ụdị hydroxytryptophan na ọrịa na degenerative cerebellar ọrịa. Arch Neurol 1995; 52: 451-5. Lelee anya.
  34. Alino, J. J., Gutierrez, J. L., na Iglesias, M. L. 5-Hydroxytryptophan (5-HTP) na MAOI (nialamide) n'ịgwọ nkụda mmụọ. A na-achịkwa ọmụmụ abụọ. Int Pharmacopsychiatry 1976; 11: 8-15. Lelee anya.
  35. Pranzatelli, M. R., Tate, E., Huang, Y., Haas, R. H., Bodensteiner, J., Ashwal, S., na Franz, D. Neuropharmacology nke myoclonus epilepsy na-aga n'ihu: nzaghachi na 5- hydroxy-L-tryptophan. Akwụkwụ na-adọ 1995; 36: 783-791. Lelee anya.
  36. Thomson, J., Rankin, H., Ashcroft, GW, Yates, CM, McQueen, JK, na Cummings, SW Ọgwụgwọ ịda mba n'ozuzu omume: ntụle nke L-tryptophan, amitriptyline, na Nchikota L-tryptophan na amitriptyline na placebo. Psychol Med 1982; 12: 741-751. Lelee anya.
  37. Trouillas, P., Garde, A., Robert, JM, Renaud, B., Adeleine, P., Bard, J., na Brudon, F. [Mmetụta nke ọrịa cerebellar syndrome n'okpuru ọchịchị ogologo oge nke 5-HTP ma ọ bụ nchikota nke 5-HTP na benserazide. A na-enyocha usoro 26 wee gụọ ma jiri usoro kọmputa mee ihe]. Mkpu Neurol. (Paris) 1982; 138: 415-435. Lelee anya.
  38. Thal, L. J., Sharpless, N. S., Wolfson, L., na Katzman, R. Ọgwụgwọ nke myoclonus na L-5-hydroxytryptophan na carbidopa: nyocha ahụike, electrophysiological, na biochemical kwuru. Ann Neurol 1980; 7: 570-576. Lelee anya.
  39. van Hiele LJ. l-5-Hydroxytryptophan na ịda mbà: usoro ọgwụgwọ mbụ gbanwere na psychiatry? Ọgwụgwọ nke ndị ọrịa 99 si na 'ọgwụgwọ na-eguzogide ọgwụ' ịda mba. Neuropsychobiology 1980; 6: 230-40. Lelee anya.
  40. Magnussen, m.na Nielsen-Kudsk, F. Bioavailability na pharmacokinetics metụtara na nwoke nke ejiri ọnụ kwuo okwu L-5-hydroxytryptophan na steeti kwụsiri ike. Acta Pharmacol Toxicol. (Copenh) 1980; 46: 257-262. Lelee anya.
  41. Trouillas, P., Garde, A., Robert, J. M., na Adeleine, P. [Mmetụta nke cerebellar mmadụ ataxia n'okpuru nlekọta ogologo oge nke 5-hydroxytryptophan]. CR Sances Acad Sci III 1-5-1981; 292: 119-122. Lelee anya.
  42. Pueschel SM, Reed RB, Cronk CE, Goldstein BI. 5-hydroxytryptophan na pyridoxine. Mmetụta ha na ụmụaka ndị nwere nsogbu Down. Am J Dis Nwa 1980; 134: 838-44. Lelee anya.
  43. Longo G, Rudoi I, Iannuccelli M, Strinati R, Panizon F. [Ọgwụgwọ isi ọwụwa dị oke mkpa na afọ mmepe na L-5-HTP (gafere okpukpu abụọ kpuru ìsì ọmụmụ na placebo)]. Pediatr Med Chir 1984; 6: 241-5. Lelee anya.
  44. Bono, G., Micieli, G., Sances, G., Calvani, M., na Nappi, G. L-5HTP ọgwụgwọ na isi isi ọwụwa: nnwale na nyocha ahụike nke ndị ọrịa na-anabata. Cephalalgia 1984; 4: 159-165. Lelee anya.
  45. Quadbeck, H., Lehmann, E., na Tegeler, J. Nkọwa nke ihe mgbochi antidepressant nke tryptophan, tryptophan / 5- hydroxytryptophan ጥምረት na nomifensine. Neuropsychobiology 1984; 11: 111-115. Lelee anya.
  46. van Praag, H. M. Na ịchọ ọnọdụ nke ihe nke antidepressants: 5-HTP / tyrosine ngwakọta na ịda mba. Adv Biochem Psychopharmacol. 1984; 39: 301-314. Lelee anya.
  47. Trouillas P. Mmetụta nke ọrịa cerebellar na nlekọta ogologo oge nke 5-HTP ma ọ bụ njikọta nke 5-HTP-benserazide: Ọnọdụ 21 nwere akara ngosi ọnụọgụ nke kọmpụta mebere. Ọrịa J Neurol Sci 1984; 5: 253-266. Lelee anya.
  48. van Praag, H. M. na de Haan, S. Chemoprophylaxis nke ịda mba. Mgbalị iji tụnyere lithium na 5- hydroxytryptophan. Acta isi mgbaka. Scand Suppl 1981; 290: 191-201. Lelee anya.
  49. van Praag, H. na de Hann, S. Nsogbu ndagide na 5-hydroxytryptophan prophylaxis. Ọrịa uche. 1980; 3: 75-83. Lelee anya.
  50. Soulairac, A. [Hypnotic edinam nke mecloqualone. Tụnyere ihe mmetụta ebebo na secobarbital]. Presse Med 4-10-1971; 79: 817-818. Lelee anya.
  51. Chase, T. N., Ng, L. K., na Watanabe, A. M. Parkinson oria. Mgbanwe site na 5-hydroxytryptophan. Ihe omumu ihe 1972; 22: 479-484. Lelee anya.
  52. Wyatt, R.J, Vaughan, T., Galanter, M., Kaplan, J., na Green, R. Mgbanwe omume nke ndị ọrịa na-adịghị ala ala nyere L-5- hydroxytryptophan. Sayensị 9-22-1972; 177: 1124-1126. Lelee anya.
  53. van Praag HM, Korf J, Dols LC, Schut T. Nnyocha nyocha nke uru amụma nke ule probenecid na ntinye nke 5-hydroxytryptophan dị ka antidepressant. Psychopharmacologia 1972; 25: 14-21. Lelee anya.
  54. Zarcone, V., Kales, A., Scharf, M., Tan, T. L., Simmons, J. Q., na Dement, W. C. Ntughari onu ogwu nke 5-hydroxytryptophan. Mmetụta dị na omume na usoro ihi ụra n'ime ụmụaka abụọ nwere ọgụgụ isi. Arch Gen Ọrịa 1973; 28: 843-846. Lelee anya.
  55. Chadwick, D., Hallett, M., Harris, R., Jenner, P., Reynolds, EH, na Marsden, CD Clinical, biochemical, na physiological atụmatụ ịmata ọdịiche myoclonus na-anabata 5-hydroxytryptophan, tryptophan nwere monoamine oxidase inhibitor, na clonazepam. Brain 1977; 100: 455-487. Lelee anya.
  56. Van Woert, M. H., Rosenbaum, D., Howieson, J., na Bowers, M. B., Jr. Nlekọta ogologo oge nke myoclonus na nsogbu ndị ọzọ na-adịghị mma na L-5- hydroxytryptophan na carbidopa. N Engl J Med 1-13-1977; 296: 70-75. Lelee anya.
  57. Nolen WA, van de Putte JJ, Dijken WA, Kamp JS. L-5HTP na ịda mbà n'obi na-eguzogide ọgwụ iji re-uptake inhibitors. Ọmụmụ ihe atụ na-emeghe na tranylcypromine. Br J Ọrịa 1985; 147: 16-22. Lelee anya.
  58. De Benedittis G, Massei R. Serotonin na-ebute ụzọ isi isi ọwụwa. A na-enyocha ihu abụọ na-aga na L-5-hydroxytryptophan vs. placebo. J Neurosurg Sci 1985; 29: 239-48. Lelee anya.
  59. Titus F, Dávalos A, Alom J, Codina A. 5-Hydroxytryptophan na methysergide na prophylaxis nke migraine. Ọnwụnwa ahụike na-enweghị usoro. Neurol 1986; 25: 327-9. Lelee anya.
  60. Santucci M, Cortelli P, Rossi PG, Baruzzi A, Sacquegna T. L-5-hydroxytryptophan versus placebo na nwata migraine prophylaxis: a abụọ-kpuru ìsì ọmụmụ ọmụmụ. Cephalalgia 1986; 6: 155-7. Lelee anya.
  61. Irwin, M. R., Marder, S. R., Fuentenebro, F., na Yuwiler, A. L-5-hydroxytryptophan na-eme ka mgbaàmà psychotic dị mma nke D-amphetamine kpatara. Ọrịa uche. Ọrịa. 1987; 22: 283-289. Lelee anya.
  62. Angst J, Woggon B, Schoepf J. Ọgwụgwọ ịda mbà n'obi na L-5-hydroxytryptophan na imipramine. Nsonaazụ nke abụọ emeghe na otu nyocha ihu abụọ. Nchịkọta ọrịa Nervenkr 1977; 224: 175-86. Lelee anya.
  63. Kahn RS, Westenberg HG, Verhoeven WM, et al. Mgbakwunye Mmetụta nke ihe serotonin precursor na uptake inhibitor na ọgba aghara nchegbu; nyocha ihu abụọ nke 5-hydroxytryptophan, clomipramine na placebo. Int Clinic Psychopharmacol 1987; 21: 33-45. Lelee anya.
  64. De Giorgis G, Miletto R, Iannuccelli M, Camuffo M, Scerni S. Isi ọwụwa na njikọta ụra ụra na ụmụaka: nyocha nke psychodiagnostic na njikwa ọmụmụ ahụike - L-5-HTP na placebo. Ọgwụ Exp Clin Res 1987; 13: 425-33. Lelee anya.
  65. Zmilacher, K., Battegay, R., na Gastpar, M. L-5-hydroxytryptophan naanị yana yana ya na onye na-eme ihe mgbochi decarboxylase na ọgwụgwọ nke ịda mba. Neuropsychobiology 1988; 20: 28-35. Lelee anya.
  66. Nolen, W. A., van de Putte, J. J., Dijken, W. A., Kamp, J. S., Blansjaar, B. A., Kramer, H. J., na Haffmans, J. Usoro ọgwụgwọ ịda mbà n'obi. II. MAO na-egbochi ịda mbà n'obi na-eguzogide ọgwụ antidepressants cyclic: abụọ na-achịkwa crossover ọmụmụ na tranylcypromine vesos L-5-hydroxytryptophan na nomifensine. Ọrịa Psychi. Scand 1988; 78: 676-683. Lelee anya.
  67. Kaneko M, Kumashiro H, Takahashi Y, Hoshino Y. L-5HTP ọgwụgwọ na usoro 5-HT ọbara mgbe L-5-HTP na-eburu ndị ọrịa dara mbà. Neuropsychobiology 1979; 5: 232-40. Lelee anya.
  68. Rousseau JJ. Mmetụta nke levo-5-hydroxytryptophan-dihydroergocristine nchikota na ịda mbà n'obi na arụmọrụ neuropsychic: ọnụọgụ abụọ na-achịkwa ebebo na-achịkwa ndị ọrịa. Ọrịa 1987; 9: 267-72. Lelee anya.
  69. Anders, T. F., Cann, H. M., Ciaranello, R. D., Barchas, J. D., na Berger, P. A. Nchoputa ndi ozo banyere ojiji nke 5-hydroxytryptophan na nwatakiri nwere oria Lesch-Nyhan. Neuropadiatrie. Ọrịa. 1978; 9: 157-166. Lelee anya.
  70. Ceci F, Cangiano C, Cairella M, et al. Ekele Mmetụta nke nchịkwa 5-hydroxytryptophan ọnụ na-eri nri na ụmụ nwanyị ndị okenye. J Neural Gbanweta 1989; 76: 109-17. Lelee anya.
  71. Jangid P, Malik P, Singh P, Sharma M, Gulia AK. Ọmụmụ ihe atụ nke ịdị irè nke l-5-hydroxytryptophan na fluoxetine na ndị ọrịa na-ebute ihe mbụ na-akpata nkụda mmụọ. Asia J Ọrịa 2013; 6: 29-34. Lelee anya.
  72. Zarcone, V. P., Jr. na Hoddes, E. Mmetụta nke 5-hydroxytryptophan na mpekere nke ụra REM na-a inụbiga mmanya ókè. Am J Ọrịa 1975; 132: 74-76. Lelee anya.
  73. Opladen, T., Hoffmann, G. F., na Blau, N. Nnyocha mba ụwa nke ndị ọrịa nwere ụkọ tetrahydrobiopterin na-egosipụta hyperphenylalaninaemia. Njegharị Metab Dis 2012; 35: 963-973. Lelee anya.
  74. Baraldi, S., Hepgul, N., Mondelli, V., na Pariante, C. M. Symptomatic ọgwụgwọ nke interferon-alpha-kpatara ịda mbà n'obi na ịba ọcha n'anya C: nyocha nyocha. J Ọrịa Psychopharmacol. 2012; 32: 531-543. Lelee anya.
  75. Pan, L., McKain, BW, Madan-Khetarpal, S., Mcguire, M., Diler, RS, Perel, JM, Vockley, J., na Brent, DA GTP-cyclohydrolase erughị eru na-anabata sapropterin na 5-HTP supplementation : enyemaka nke ọgwụgwọ-ịda mbà n'obi na omume igbu onwe. Okwu BMJ. 2011; 2011 Eleghị anya.
  76. Friedman, J., Roze, E., Abdenur, JE, Chang, R., Gasperini, S., Saletti, V., Wali, GM, Eiroa, H., Neville, B., Felice, A., Parascandalo, R, Zafeiriou, DI, Arrabal-Fernandez, L., Dill, P., Eichler, FS, Echenne, B., Gutierrez-Solana, LG, Hoffmann, GF, Hyland, K., Kusmierska, K., Tijssen, MA, Lutz, T., Mazzuca, M., Penzien, J., Poll-The BT, Sykut-Cegielska, J., Szymanska, K., Thony, B., na Blau, N. Sepiapterin reductase erughi: ọgwụgwọ mimic nke ọrịa ụbụrụ. Ann Neurol. 2012; 71: 520-530. Lelee anya.
  77. Jukic T, Rojc B, Boben-Bardutzky D, Hafner M, Ihan A. Iji mgbakwunye nri na D-phenylalanine, L-glutamine na L-5-hydroxytriptophan na mbelata mmanya mgbaàmà. Coll Antropol 2011; 35: 1225-30. Lelee anya.
  78. Sarris, J. Clinical depression: ihe akaebe dabere na usoro ọgwụgwọ na-arụkọ ọrụ ọnụ. Ọzọ.Ther. Health Med. Ọrịa. 2011; 17: 26-37. Lelee anya.
  79. Dill, P., Wagner, M., Somerville, A., Thony, B., Blau, N., na Weber, P. Ọkpụkpụ ụmụaka: nlele paroxysmal, anya elu, na hypotonia: njirimara nke sepiapterin reductase deficiency. Ihe Ọrịa Ọrịa 1-31-2012; 78: e29-e32. Lelee anya.
  80. Horvath, GA, Selby, K., Poskitt, K., Hyland, K., Waters, PJ, Coulter-Mackie, M., na Stockler-Ipsiroglu, SG Hemiplegic migraine, njigide, na-aga n'ihu spastic paraparesis, nsogbu uche, na coma n'ime ụmụnne nwere serotonin dị ala. Cephalalgia 2011; 31: 1580-1586. Lelee anya.
  81. Morrison, K. E. Nhazi usoro ihe omuma dum na-agwa ọgwụgwọ: ọgwụ nke ahaziri mmadụ ga-aga n'ihu. Ọrịa Chem 2011; 57: 1638-1640. Lelee anya.
  82. Bainbridge, MN, Wiszniewski, W., Murdock, DR, Friedman, J., Gonzaga-Jauregui, C., Newsham, I., Reid, JG, Fink, JK, Morgan, MB, Gingras, MC, Muzny, DM, Hoang, LD, Yousaf, S., Lupski, JR, na Gibbs, RA Usoro usoro ihe omumu nke kachasị maka njikwa ọrịa. Ntụgharị Sci.Med 6-15-2011; 3: 87re3. Lelee anya.
  83. den Boer JA, Westenberg HG. Ahụhụ, neuroendocrine, na mmetụta nchịkwa nke nchịkwa 5-hydroxytryptophan na ọgba aghara. Ọrịa ọrịa 1990; 31: 267-78. Lelee anya.
  84. Adamsen, D., Meili, D., Blau, N., Thony, B., na Ramaekers, V. Autism metụtara obere 5-hydroxyindolacetic acid na CSF na heterozygous SLC6A4 gene Gly56Ala tinyere 5-HTTLPR L / L ndị na-akwalite ụdị . Mpempe akwụkwọ. 2011; 102: 368-373. Lelee anya.
  85. Cross, D. R., Kellermann, G., McKenzie, L. B., Purvis, K. B., Hill, G. J., na Huisman, H. Ihe omuma amino acid a choputara na umuaka ndi nwere nsogbu. Nlekọta Ahụike Childmụaka. Ọrịa. 2011; 37: 671-678. Lelee anya.
  86. Gendle, M. H. na Golding, A. C. Oral ochichi nke 5-hydroxytryptophan (5-HTP) na-emebi mkpebi n'ime ihe mgbagwoju anya mana ọ bụghị n'ihe egwu: ihe akaebe sitere na Ọrụ Igba Egwuregwu Iowa. Hum Psychopharmacol. Ọrịa. 2010; 25: 491-499. Lelee anya.
  87. Iovieno, N., Dalton, E. D., Fava, M., na Mischoulon, D. Nke abụọ nke eke antidepressants: nyocha na nkatọ. J. Na-emetụta. Ọrịa. 2011; 130: 343-357. Lelee anya.
  88. Leu-Semenescu, S., Arnulf, I., Decaix, C., Moussa, F., Clot, F., Boniol, C., Touitou, Y., Levy, R., Vidailhet, M., na Roze, E. Sra na uda ụda na-ebute ọnwụ nke serotonin. 3ra 3-1-2010; 33: 307-314. Lelee anya.
  89. Onyinye RR. Ọgwụgwọ ọkụ ọkụ na-acha menopausal na 5-hydroxytryptophan. Maturitas 2010; 65: 383-5. Lelee anya.
  90. Izu, B. S. Formulations nke ihe mgbakwunye nri na akwụkwọ nri maka ezumike na omume nchegbu: Relarian. Ahụike Sci Monit. Ọrịa. 2009; 15: RA256-RA262. Lelee anya.
  91. Rondanelli M, Klersy C, Iadarola P, et al. Satiety na amino-acid profaịlụ na ụmụ nwanyị buru oke ibu mgbe a gwọchara ha site na iji ahịhịa sitere n'okike wepụta usoro ịgba sublingual. Int J Obes (Lond) 2009; 33: 1174-1182. Lelee anya.
  92. Maissen CP, Ludin HP. [Nkọwa nke mmetụta nke 5-hydroxytryptophan na propranolol na oge etiti nke migraine]. Schweiz Med Wochenschr 1991; 121: 1585-90. Lelee anya.
  93. Shell W, Bullias D, Charuvastra E, et al. Ọnwụnwa amino acid siri ike, nke a na-achịkwa ebe a na-achịkwa ebe a na-ehi ụra na oge na mma ụra. Am J Igwe 2010; 17: 133-9. Lelee anya.
  94. Trujillo-Martin, M. M., Serrano-Aguilar, P., Monton-Alvarez, F., na Carrillo-Fumero, R. fectdị mma na nchekwa nke ọgwụgwọ maka ataxias na-emebi emebi: nyocha nyocha. Nsogbu Mov. 6-15-2009; 24: 1111-1124. Lelee anya.
  95. Rothman, R. B. Ọgwụgwọ oke ibu na "nchikota" pharmacotherapy. Am J Igwe 2010; 17: 596-603. Lelee anya.
  96. Chae, HS, Kang, OH, Choi, JG, Oh, YC, Lee, YS, Jang, HJ, Kim, JH, Park, H., Jung, KY, Sohn, DH, na Kwon, DY 5-hydroxytryptophan na-eme usoro protein protein protein kinase extracellular-signal na-edozi ụzọ protein kinase iji gbanwee usoro cyclooxygenase-2 na inducible nitric oxide synthase okwu na mkpụrụ ndụ RAW 264.7. Biol Pharm ehi 2009; 32: 553-557. Lelee anya.
  97. Hendricks, E. J., Rothman, R. B., na Greenway, F. L. Olee otú ndị oké ibu dọkịta si eji ọgwụ ọjọọ eme ihe iji na-agwọ oke ibu. Ibu. (Silver.Spring) 2009; 17: 1730-1735. Lelee anya.
  98. Longo, N. Ọrịa nke biopterin metabolism. Njegharị Metab Dis 2009; 32: 333-342. Lelee anya.
  99. Pons, R. Ọdịdị phenotypic nke pediatric neurotransmitter ọrịa na infantile parkinsonism. Njegharị Metab Dis 2009; 32: 321-332. Lelee anya.
  100. Schaefer, M., Winterer, J., Sarkar, R., Uebelhack, R., Franke, L., Heinz, A., na Friebe, A. Ọnọdụ atọ nke ihe ịga nke ọma tryptophan gbakwunye ma ọ bụ monotherapy nke ịba ọcha n'anya C na IFNalpha -nsogbu onodu obi. Psychosomatics 2008; 49: 442-446. Lelee anya.
  101. Jacobsen, JP, Nielsen, EO, Hummel, R., Redrobe, JP, Mirza, N., na Weikop, P. Insensitivity nke ụmụ oke NMRI iji họrọ ndị na-emechi serotonin reuptake na ọdụ nkwụsị ọdụ nwere ike gbanwee site na ọgwụgwọ na 5 -hydroxytryptophan. Psychopharmacology (Berl) 2008; 199: 137-150. Lelee anya.
  102. Liu, K. M., Liu, T. T., Lee, N. C., Cheng, L. Y., Hsiao, KJ, na Niu, D. M. Nlekọta ogologo oge nke ndị ọrịa China na-agwọ ọrịa n'oge maka ụkọ 6-pyruvoyl-tetrahydropterin synthase. Arch Neurol. 2008; 65: 387-392. Lelee anya.
  103. Horvath, GA, Stockler-Ipsiroglu, SG, Salvarinova-Zivkovic, R., Lillquist, YP, Connolly, M., Hyland, K., Blau, N., Rupar, T., na Mmiri, PJ Autosomal recessive GTP cyclohydrolase I erughị ala na-enweghị hyperphenylalaninemia: ihe akaebe nke usoro phenotypic dị n'etiti ụdị ndị na-achịkwa ma na-enweghachi. Molta Geet.Metab 2008; 94: 127-131. Lelee anya.
  104. Morrow, J. D., Vikraman, S., Imeri, L., na Opp, M. R. Mmetụta nke mmezi serotonergic site na 5-hydroxytryptophan na ụra na ahụ ọkụ nke C57BL / 6J na ụmụ oke na-enweghị oke interleukin-6 bụ ọgwụ na oge metụtara. Ihi ụra 1-1-2008; 31: 21-33. Lelee anya.
  105. Meolie, AL, Rosen, C., Kristo, D., Kohrman, M., Gooneratne, N., Aguillard, RN, Fayle, R., Troell, R., Townsend, D., Claman, D., Hoban, T., na Mahowald, M. Oral na-edeghị ọgwụ maka ehighị ụra nke ọma: nyocha nke ngwaahịa na obere ihe akaebe. J Ahụ .Sra Med 4-15-2005; 1: 173-187. Lelee anya.
  106. Cangiano C, Ceci F, Cairella M, et al. Na Na Na Na Na Mmetụta nke 5-hydroxytryptophan na-eri nri na ịgbaso usoro ọgwụ nri na isiokwu ndị toro eto. Adv Exp Med Biol 1991; 294: 591-3. Lelee anya.
  107. Petre-Quadens, O. na De Lee, C. 5-Hydroxytryptophan ma hie ụra na Down’s syndrome. Nyocha. J Neurol Sci 1975; 26: 443-453. Lelee anya.
  108. Lesch, K. P., Hoh, A., Disselkamp-Tietze, J., Wiesmann, M., Osterheider, M., na Schulte, H. M. 5-Hydroxytryptamine1A na-azaghachi nzaghachi na nsogbu na-agwụ aghara. Tụnyere ndị ọrịa na njikwa. Arch Gen Ọrịa 1991; 48: 540-547. Lelee anya.
  109. Halladay, AK, Wagner, GC, Sekowski, A., Rothman, RB, Baumann, MH, na Fisher, H. Mgbanwe na ị alcoholụbiga mmanya ókè, nkwụsịtụ iwepụ, na nnyefe monoamine na oke ndị a na-agwọ na phentermine na 5-hydroxy-L-tryptophan . Synapse 2006; 59: 277-289. Lelee anya.
  110. Curcio, J. J., Kim, L. S., Wollner, D., na Pockaj, B. A. Ike nke 5-hydryoxytryptophan maka mbelata ọkụ ọkụ: nkwupụta. Nyocha ọzọ Med 2005; 10: 216-221. Lelee anya.
  111. Victor, S. na Ryan, S. W. Ọgwụ maka igbochi isi ọwụwa migraine na ụmụaka. Cochrane Ebe nchekwa. Syst. Rev 2003;: CD002761. Lelee anya.
  112. George DT, Lindquist T, Rawlings RR, et al. Nlekọta ọgwụ nke ọgwụ abstinence na ndị ọrịa na-a alcoholụbiga mmanya ókè: enweghị nrụpụta nke 5-hydroxytryptophan ma ọ bụ levodopa. Nlekọta Ọgwụ Pharmacol Ther 1992; 52: 553-60. Lelee anya.
  113. Shaw, K., Turner, J., na Del Mar, C. Tryptophan na 5-hydroxytryptophan maka ịda mba. Cochrane Database. Syst Rev 2002;: CD003198. Lelee anya.
  114. Ciaranello, R. D., Anders, T. F., Barchas, J. D., Berger, P. A., na Cann, H. M. Ojiji nke 5-hydroxytryptophan n’ime nwatakiri nwere oria Lesch-Nyhan. Nwa Psychiatry Hum Dev 1976; 7: 127-133. Lelee anya.
  115. Anderson, L. T., Herrmann, L., na Dancis, J. Mmetụta nke L-5-hydroxytryptophan na-egbu onwe ya na ọrịa Lesch-Nyhan: akụkọ na-adịghị mma. Neuropadiatrie. Ọrịa. 1976; 7: 439-442. Lelee anya.
  116. Growdon, J. H., Young, R. R., na Shahani, B. T. L-5-hydroxytryptophan na ọgwụgwọ nke ọtụtụ syndromes dị iche iche nke myoclonus bụ ihe ama ama. Ihe omumu ihe 1976; 26: 1135-1140. Lelee anya.
  117. Takahashi S, Kondo H, Kato N. Mmetụta nke l-5-hydroxytryptophan na ụbụrụ monoamine metabolism na nyocha nke mmetụta ahụike ya na ndị ọrịa dara mbà. J Ọrịa Res 1975; 12: 177-87. Lelee anya.
  118. Preshaw RM, Leavitt D, Hoag G. Ihe mgbakwunye nri 5-hydroxytryptophan na urinary 5-hydroxyindole acetic acid. CMAJ 2008; 178: 993. Lelee anya.
  119. Byerley WF, Judd LL, Reimherr FW, Nnukwu BI. 5-Hydroxytryptophan: nyocha nke nrụgide antidepressant ya na mmetụta ọjọọ. J Clin Psychopharmacol 1987; 7: 127-37 .. Lelee anya.
  120. Shaw K, Turner J, Del Mar C. Tryptophan na 5-hydroxytryptophan maka ịda mba. Cochrane Database Syst Rev 2002;: CD003198. Lelee anya.
  121. Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V. Nyocha nke okpukpu abụọ nke 5-hydroxytryptophan na placebo na ọgwụgwọ nke ọrịa fibromyalgia bụ isi. J Int Med 1990; 18: 201-9. Lelee anya.
  122. Johnson KL, Klarskov K, Benson LM, et al. Obi ụtọ Ọnụnọ nke elu X na ogige ndị metụtara ya: mmetọ a kọrọ na ọ metụtara 5-hydroxy-L-tryptophan metụtara ọrịa eosinophilia-myalgia. J Rheumatol 1999; 26: 2714-7. Lelee anya.
  123. Singhal AB, Caviness VS, Begleiter AF, et al. Cerebral vasoconstriction na strok mgbe eji ọgwụ serotonergic. Ihe nyocha. 2002; 58: 130-3. Lelee anya.
  124. U. S. Nchịkwa nri na ọgwụ ọjọọ, Centerlọ Ọrụ Maka Nchedo Nri na Nutrition Na-ahụ Maka, ,lọ Ọrụ Na-ahụ Maka Nri, Nlekọta, na Mmeju Nri. Akwụkwọ Ozi na L-Tryptophan na 5-hydroxy-L-tryptophan, February 2001.
  125. Nardini M, De Stefano R, Iannuccelli M, et al. Ọgwụgwọ ịda mba na L-5-hydroxytryptophan tinyere chlorimipramine, ọmụmụ ihe abụọ. Int J Clin Pharmacol Ncha 1983; 3: 239-50. Lelee anya.
  126. Ribeiro CA. L-5-Hydroxytryptophan na prophylaxis nke nsogbu na-adịghị ala ala-ụdị isi ọwụwa: ọmụmụ abụọ na-achịkwa, nke enweghị isi, nke a na-achịkwa. Isi ọwụwa 2000; 40: 451-6. Lelee anya.
  127. Poldinger W, Calanchini B, Schwarz W. A arụ ọrụ-akụkụ obibia ịda mbà n'obi: serotonin erughi dị ka a lekwasịrị syndrome na ntụnyere nke 5-hydroxytryptophan na fluvoxamine. Ọrịa Psychology 1991; 24: 53-81. Lelee anya.
  128. Sternberg EM, Van Woert MH, Nwa okorobịa SN, et al. Mmepe nke oria di ka scleroderma dika ogwugwo ya na L-5-hydroxytryptophan na carbidopa. N Engl J Med 1980; 303: 782-7. Lelee anya.
  129. Nchịkwa nri na ọgwụ ọjọọ na U.S. Adịghị ọcha gosipụtara na mgbakwunye nri 5-hydroxy-L-tryptophan. Akwụkwọ Nkwupụta Okwu FDA, August 31, 1998; T98-48.
  130. Meyer JS, Welch KM, Deshmukh VD, et al. Mgbakwunye Neurotransmitter precursor amino acid na ọgwụgwọ nke ọrịa nkwarụ nke ọtụtụ infarct na ọrịa Alzheimer. J Amer Geriat Soc 1977; 25: 289-98. Lelee anya.
  131. Trouillas P, Brudon F, Adeleine P. Mmelite nke cerebellar ataxia na ụdị levorotatory nke 5-hydroxytryptophan: nyocha ihu abụọ nwere ọnụọgụ ọnụọgụ ọnụọgụ ọnụọgụ. Nyocha Neurol 1988; 45: 1217-22. Lelee anya.
  132. Kahn RS, Westenberg HG. L-5-hydroxytryptophan na ọgwụgwọ nsogbu nsogbu. J Na-emetụta Nsogbu 1985; 8: 197-200. Lelee anya.
  133. Cangiano C, Ceci F, Cancino A, et al. Ọgwụ Omume iri nri na ịgbaso usoro ọgwụ nri na isiokwu ndị toro eto buru ibu ejiri 5-hydroxytryptophan mesoo. Am J Clin Nutr 1992; 56: 863-7. Lelee anya.
  134. Sarzi Puttini P, Caruso I. Ọrịa fibromyalgia nke mbụ na 5-hydroxy-L-tryptophan: ọmụmụ ihe mmeghe 90. J Int Med Res 1992; 20: 182-9. Lelee anya.
  135. Nakajima T, Kudo Y, Kaneko Z. Nyocha nyocha nke 5-hydroxy-L-tryptophan dị ka ọgwụ antidepressant. Folia Ọrịa Neurol Jpn 1978; 32: 223-30. Lelee anya.
  136. Michelson D, Page SW, Casey R, et al. Ọrịa ọrịa eosinophilia-myalgia metụtara ọrịa metụtara L-5-hydroxytryptophan. J Rheumatol 1994; 21: 2261-5. Lelee anya.
  137. Birdsall TC. 5-Hydroxytryptophan: Nlekọta Nlekọta Ahụ Nke Serotonin. Nyocha ọzọ Med 1998; 3: 271-80. Lelee anya.
Nyochaa ikpeazụ - 12/29/2020

Isiokwu ỌHụRụ

Fluorescein Angiography
Ahụ Ike

Fluorescein Angiography

Kedu ihe bụ Fluore cein Angiography?A fluore cein angiography bụ u oro ọgwụgwọ nke a na-etinye agba agba fluore cent n'ime ọbara. Agba ya na-ego i ihe akwara ọbara n’azụ anya ka e wee ee ha foto....
Caput Medusae
Ahụ Ike

Caput Medusae

Gịnị bụ caput medu ae?Caput medu ae, oge ụfọdụ a na-akpọ akara nkwụ, na-ezo aka na ntopute nke netwọkụ na - enweghị mgbu, vein fụrụ akpụ na gburugburu afọ gị. Ọ bụ ezie na ọ bụghị ọrịa, ọ bụ ihe ịrịb...